A

Akeso
9926

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
HK$89.76B
EV
HK$86.08B
Shares Outstanding
897.85M
Beta
0.58

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$89.97
P/E 2025E
256.19x
P/Revenue 2025E
22.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Akeso, Inc.

gainify

A

Akeso, Inc.

9926

Akeso, Inc., a biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer (GC), gastroesophageal junction (GEJ) cancer, ESCC,...

Sector

Healthcare

Industry

Biotechnology

CEO

Xia, Yu

Employees

3,035

IPO Date

2020-04-24

Headquarters

No. 6, Shennong Road, Torch Development Zone, Zhongshan, Guangdong Province, 528437, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved